Riskpilot← Back to searchSign inGet full accessSplend Medical AB
ABActiveOrg 5567629273Karlbergsvägen 34 AOther education n.e.c. · NACE 8559Est. 20081 employees
Revenue 2025
SEK 1,9M
-12% vs 2024
EBITDA margin
46.7%
-21% vs 2024
Equity ratio
82.8%
Financial strength
Net profit 2025
SEK 1,1M
-16% vs 2024
| Revenue | SEK 1,9M | -12% |
| EBITDA | SEK 904K | -21% |
| Net profit | SEK 1,1M | -16% |
| Total assets | SEK 8,1M | +5% |
| Equity | SEK 6,7M | +12% |
| Employees | 1 | — |
Legal name
Splend Medical AB
Org number
5567629273
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
25 juli 2008
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är sjukvård och medicinsk forskning, medicinsk vård, rådgivning, forskning, undervisning, kongressbevakning, handel med värdepapper och därmed förenlig verksamhet.
Address
Karlbergsvägen 34 A
Email
grantson@algonet.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 293 | 2 167 | 2 219 | 2 201 | 1 935 |
| Staff expenses | — | — | — | −342 | −421 |
| EBITDA | 1 512 | 1 253 | 1 297 | 1 145 | 904 |
| Depreciation & amort. | −0 | −0 | −0 | −31 | −81 |
| EBIT | 1 512 | 1 253 | 1 297 | 1 114 | 823 |
| Net financials | 19 | 22 | 119 | 218 | 205 |
| Profit before tax | 1 748 | 1 511 | 1 663 | 1 667 | 1 407 |
| Tax | −378 | −317 | −351 | −352 | −297 |
| Net profit | 1 370 | 1 194 | 1 312 | 1 315 | 1 109 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 923 | 5 837 | 6 731 | 7 775 | 8 144 |
| Equity | 3 410 | 4 204 | 5 116 | 6 031 | 6 741 |
| Long-term debt | 0 | 0 | 0 | — | 49 |
| Short-term debt | 315 | 672 | 902 | 1 366 | 1 355 |
| Total debt | 315 | 672 | 902 | 1 366 | 1 404 |
EBITDA margin
46.7%
This company
15.8%
Market median
+196% vs market
20212025
Equity ratio
82.8%
This company
38.2%
Market median
+117% vs market
20212025
Return on equity
16.5%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
57.3%
This company
8.1%
Market median
+607% vs market
20212025
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20212025
Debt / equity
0.21×
This company
0.62×
Market median
+66% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ÅK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Splend Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åsa Kristina Grantson | Chief Executive Officer | 0 companies |
| Börje Samuel Marklund | Deputy Board Member | 0 companies |
| George Kofi Grantson | Chairman | 0 companies |